Medline Inc. (MDLN) Stock Score, Valuation & Financial Research
Medline Inc. is in the Healthcare sector and Medical - Instruments & Supplies industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. The current Wall Street Score is 35/100.
Quick answer for MDLN
Medline Inc. currently has a Wall Street Score of 35/100. The stored market price is $32.53. Its financial score is 33/100. Its valuation score is 33/100. These figures are a research snapshot, not a buy or sell recommendation.
What Medline Inc. does
Medline Inc. is a global manufacturer of medical and surgical products, catering to a broad spectrum of healthcare providers. Their clientele includes hospitals, surgical centers, physician practices, post-acute care facilities, and nursing homes, both domestically and worldwide. The company's operations are divided into two primary divisions: the Medline Brand and Supply Chain Solutions. The Medline Brand division focuses on the production and sourcing of its proprietary medical products, categorized into three key areas: Within Frontline Care, Medline provides a wide array of patient-facing medical and surgical items. This encompasses essentials like wound care treatments, examination gloves, skin and incontinence products, sanitation supplies, various textiles, hand sanitizers, durable medical equipment (DME), patient-specific plastic goods, and decolonization and infection control so
MDLN financial snapshot
- Wall Street Score:
- 35/100
- Current price:
- $32.53
- Market capitalization:
- $27.51B
- Revenue:
- $29.14B
- Net income:
- $964.0M
- Free cash flow:
- $1.30B
- Cash:
- $2.24B
- Total debt:
- $12.64B
- EPS:
- 1.43
- P/E ratio:
- 22.7x
- Financial score:
- 33/100
- Valuation score:
- 33/100
- Revenue score:
- 25/100
What stands out
- Reported year-over-year revenue growth is +0.0%.
- Free cash flow is $1.30B, showing positive cash generation.
- The balance sheet shows $2.24B of cash versus $12.64B of total debt, so leverage deserves attention.
What the numbers mean
Its current valuation score is 33/100, which Wall Street Score classifies as weak within the model's valuation framework.
The financial score is 33/100. This is a starting point for reviewing liquidity, leverage and cash-flow strength rather than a stand-alone recommendation.
A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.
Data freshness: Financial data last refreshed 2026-07-24.
How to research MDLN
Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.
Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks
Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.